The euro notes carry Boston Scientific's full, unconditional guarantee; both offerings are expected to close Dec. 1, 2026, subject to customary conditions.
Up to 54,545,455 shares priced at $0.0275 each; closing is expected on or about Nov. 26, with proceeds for exploration and development at Bull River Mine.
Shareholders of record at close of business Dec. 2 will receive the cash payment; the board approved a regular quarterly dividend payable Dec. 16, 2026.
The atlas spans more than 200 disease-relevant cell lines; researchers can use CellularAI to predict how untested cell types respond to genetic changes.